Feronia Inc. announced changes to its Board of Directors. The company announced that Mr. Frank Braeken, currently an independent, non-executive director of the Company, has been appointed Non-Executive Chairman. Mr. Braeken has extensive experience in the Fast Moving Consumer Goods (FMCG) sector including 26 years spent with Unilever where he lived and worked in nine countries on four continents. In 2009, Mr. Braeken became head of Unilever’s Namca region with responsibility for markets across North Africa, the Middle East and Central Africa. The company also announced the appointment of four new Non-Executive Directors namely: Mr. Nicholas Thompson CBE, Mrs. Monique Gieskes, Mr. David Osborne and Mr. David Easton. Nick Thompson CBE, is the former CEO of New Britain Palm Oil (NBPOL) and brings a wealth of palm oil industry experience to the Feronia Board. Mrs. Monique Gieskes was born in Kinshasa and educated in Belgium and the USA. For more than 30 years Monique’s career has been focused on managerial, commercial and legal affairs in Africa, Europe and Asia. Mr. David Easton and Mr. David Osborne also join the Feronia Board as representatives of CDC Group Plc. David Easton is an Investment Director and Head of Consumer Businesses at CDC Group Plc. David led CDC’s initial investment in Feronia in 2013 and leads CDC’s investment programme across agribusiness, retail, healthcare and education investing in many companies across Africa and South Asia. David Osborne is a director and Head of Portfolio Management at CDC Group Plc. Prior to joining CDC he spent 24 years at 3i Group plc in both London and Singapore. Mr. Keith Alexander and Mr. Joel Strickland will be stepping down as Non-Executive Directors of the Company although Mr. Alexander will remain as Chairman of the Company’s Environmental, Social and Governance Board Committee. Following these changes the Board of Directors of Feronia Inc. will consist of the following individuals: Frank Braeken – Independent Non-Executive Chairman; Xavier de Carniere - Chief Executive Officer, Executive Director; Ravi Sood – Executive Director; Monique Gieskes – Independent Non-Executive Director; Nicholas Thompson CBE – Independent Non-Executive Director; Nigel Gourlay – Independent Non-Executive Director; David Osborne – CDC Group Plc Nominee, Non-Executive Director; David Easton – CDC Group Plc Nominee, Non-Executive Director; Peter Van As – Phatisa Nominee, Non-Executive Director; David White – Phatisa Nominee, Independent Non-Executive Director. The changes to the Board are subject to the approval of the TSX Venture Exchange.